New Market Study: "Pre-Diabetes/Impaired Glucose Tolerance - Pipeline Review, H2 2012"
Global Markets Direct's, 'Pre-Diabetes/Impaired Glucose Tolerance - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Pre-Diabetes/Impaired Glucose Tolerance, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pre-Diabetes/Impaired Glucose Tolerance. Pre-Diabetes/Impaired Glucose Tolerance - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release